Sign in
Active, not recruitingNo phase

Virtual Reality Intervention for Patients Undergoing BMT

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
80 people, planned
Started
20 Dec 2022
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • BMT-VR
Record updated
15 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adult patients (age > 18 years) with hematologic malignancy admitted for autologous or allogeneic BMT
  • Ability to comprehend, read, and respond to questions in English as BMT-VR is only available in English

Who cannot take part

  • Patients undergoing BMT for benign hematologic conditions
  • Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believes prohibits informed consent or compliance with study procedures
  • Patients undergoing outpatient BMT

Where in United States

  • Massachusetts General Hospital Cancer CenterBoston, United States

About the trial

What the trial wants to find out

The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone.

Read full original descriptionShow less

The BMT-VR intervention has several components:

1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports. 2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes. 3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care

The 2 groups in the trial

  • BMT-VR GroupTreatment being tested

    * Participants will complete the BMT-VR intervention during their BMT hospitalization, which contains six sections. * Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes * 10-20 participants will complete exit interviews to ascertain more feedback on the BMT-VR intervention.

    Treatment: BMT-VR

  • Usual careNo study treatment, for comparison

    * Participants will receive usual transplant care by their BMT team * Participants will complete study questionnaires to assess their quality of life and psychological outcomes

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Controlled Trial of a Virtual Reality Psychosocial Intervention to Promote Coping for Patients Undergoing Bone Marrow Transplantation (BMT-VR)
Record updated
15 May 2026